Erythropoietin use in the critically ill: current evidence.
Warrillow
Stephen J
SJ
Department of Intensive Care, Austin Health, Melbourne, VIC, Australia. Stephen.Warrillow@austin.org.au
D000740:Anemia / Q000188:drug therapy; D016638:Critical Illness; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa